retatrutide ly3437943 triple agonist gip glp-1 glucagon just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Retatrutide (LY3437943): Mechanism of Action
Description
A population-based study from Scandinavia provides some real-world information.
Evaluating what the research shows about GLP-1 medications and depression and suicidal ideation.
CBS News medical correspondent Dr
pooling data for lixisenatide (Adlyxin, Sanofi), liraglutide (Victoza,
The present study was designed to assess GLP-1-induced diuresis and natriuresis in rats with HF and its interactions with renal nerve activity
GLP-Activate is your secret weapon for taming cravings and torching stubborn fat
